2024-10-22 - Analysis Report
## Cigna Group (CI) Stock Analysis

Here is a comprehensive analysis of Cigna Group (CI) stock, encompassing key financial metrics, recent performance, and market sentiment.

**1. Performance Comparison:**

Cigna Group (CI) has outperformed the S&P 500 (VOO) over the period analyzed, generating a cumulative return of 145.85% compared to VOO's 137.88%. This represents a **7.97%** outperformance, placing it at the **38.31%** percentile of historical performance relative to the S&P 500. 

**Company Overview:**

Cigna is a global health services company that provides health insurance, pharmacy benefits, and other related services. 

**2. Recent Price Movement:**

* **Closing Price:** $336.0
* **5-day Moving Average:** $349.6
* **20-day Moving Average:** $347.38
* **60-day Moving Average:** $348.12

CI is currently trading below all three moving averages, suggesting potential downward pressure.

**3. Technical Indicators:**

* **RSI:** 40.98 - This indicates a slightly oversold condition, suggesting a potential bounce back.
* **PPO:** -0.01 - This indicates a slight bearish momentum, suggesting potential downward pressure.
* **Delta_Previous_Relative_Divergence:** -14.5 -  This negative value suggests a short-term decline in relative performance.
* **Expected Return:** 13.62% - This indicates a long-term (2+ years) expected return exceeding the S&P 500, suggesting potential upside for long-term investors.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-01 | 5.51 | $60.52B |
| 2024-05-02 | -0.97 | $57.26B |
| 2023-11-02 | 4.79 | $49.05B |
| 2023-08-03 | 4.96 | $48.59B |
| 2024-08-01 | 4.96 | $48.59B |

Cigna's most recent earnings report (2024-08-01) showed a beat on both EPS and revenue expectations. The company reported an EPS of $5.51, exceeding analyst estimates of $4.80. Revenue also surpassed expectations, reaching $60.52 billion against a projected $59.24 billion. 

**5. News and Recent Issues:**

* **Analyst Opinions:** Overall sentiment towards CI is positive, with a consensus Buy rating among analysts. 
* **Performance Highlights:** Cigna is well-positioned in the healthcare sector, benefiting from its diversification across segments and a strong market share. 
* **Recent Market Outlook:** Cigna's strong earnings performance suggests a positive outlook, but potential headwinds exist, such as increasing healthcare costs and regulatory changes.  
* **Finbold:** Cigna's recent earnings exceeded expectations, driving share price gains. However, the overall market outlook remains cautious due to macro-economic concerns.

**6. Overall Analysis:**

Cigna's stock performance demonstrates resilience and outperformance compared to the S&P 500. While short-term indicators suggest some pressure, recent earnings suggest strong fundamentals. Long-term investors may consider CI for potential returns exceeding the market average, particularly with a robust healthcare sector outlook. 

**7.  Disclaimer:** This analysis is for informational purposes only and should not be considered investment advice. Always consult with a qualified financial advisor before making any investment decisions. 
